Results 71 to 80 of about 187,845 (400)

Effect of the Biopolymer Carrier on Staphylococcus aureus Bacteriophage Lytic Activity

open access: yesBiomolecules, 2022
The use of implant materials is always associated with the risk of infection. Moreover, the effectiveness of antibiotics is reduced due to antibiotic-resistant pathogens.
Liga Stipniece   +3 more
doaj   +1 more source

A Cryptic Non-Inducible Prophage Confers Phage-Immunity on the Streptococcus thermophilus M17PTZA496 [PDF]

open access: yes, 2018
open9openda Silva Duarte, Vinícius; Giaretta, Sabrina; Campanaro, Stefano; Treu, Laura; Armani, Andrea; Tarrah, Armin; Oliveira de Paula, Sérgio; Giacomini, Alessio; Corich, Vivianada Silva Duarte, Vinícius; Giaretta, Sabrina; Campanaro, Stefano; Treu ...

core   +1 more source

Prolongation of Fate of Bacteriophages In Vivo by Polylactic-Co-Glycolic-Acid/Alginate-Composite Encapsulation

open access: yesAntibiotics, 2022
With concern growing over antibiotics resistance, the use of bacteriophages to combat resistant bacteria has been suggested as an alternative strategy with which to enable the selective control of targeted pathogens.
Sang-Guen Kim   +9 more
doaj   +1 more source

Characterization of novel bacteriophages for biocontrol of bacterial blight in leek caused by Pseudomonas syringae pv. porri [PDF]

open access: yes, 2016
Pseudomonas syringae pv. porri, the causative agent of bacterial blight in leek (Allium porrum), is increasingly frequent causing problems in leek cultivation. Because of the current lack of control measures, novel bacteriophages were isolated to control
Anneleen eVolckaert   +16 more
core   +3 more sources

Application of bacteriophages [PDF]

open access: yesMicrobiology Australia, 2017
The emergence of antibiotic-resistant bacteria and decrease in the discovery rate of novel antibiotics takes mankind back to the ‘pre-antibiotic era' and search for alternative treatments. Bacteriophages have been one of promising alternative agents which can be utilised for medicinal and biological control purposes in agriculture and related fields ...
Aminov, Rustam   +14 more
openaire   +4 more sources

Successful treatment of antibiotic resistant poly-microbial bone infection with bacteriophages and antibiotics combination.

open access: yesClinical Infectious Diseases, 2019
A patient with a trauma-related left tibial infection associated with XDR Acinetobacter baumannii and MDR Klebsiella pneumoniae was treated with bacteriophages and antibiotics. Tissue healing and eradication of positive cultures were rapidly observed. As
R. Nir-Paz   +21 more
semanticscholar   +1 more source

Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. [PDF]

open access: yes, 2017
The practice of phage therapy, which uses bacterial viruses (phages) to treat bacterial infections, has been around for almost a century. The universal decline in the effectiveness of antibiotics has generated renewed interest in revisiting this practice.
Koskella, Britt, Lin, Derek, Lin, Henry
core   +1 more source

Genetically modified bacteriophages creating for the treatment of infections caused by multidrug resistant bacteria (review)

open access: yesФундаментальная и клиническая медицина, 2022
Antibiotic resistance represents an urgent and unresolved issue due to a rapid spread of multidrug-resistance organisms (MDROs). An alternative approach is the medical use of bacteriophages which have selective and lytic activity against specific ...
K. M. Bagandova   +8 more
doaj   +1 more source

Biomimetic hydroxyapatite nanocrystals are an active carrier for Salmonella bacteriophages [PDF]

open access: yes, 2019
open access articlePurpose: The use of bacteriophages represents a valid alternative to conventional antimicrobial treatments, overcoming the widespread bacterial antibiotic resistance phenomenon.
Capparelli, Rosanna   +12 more
core   +2 more sources

Ethics framework for treatment use of investigational drugs

open access: yesBMC Medical Ethics, 2020
Background Expanded access is the use of investigational drugs (IDs) outside of clinical trials. Generally it is performed in patients with serious and life-threatening diseases who cannot be treated satisfactorily with authorized drugs.
Jan Borysowski, Andrzej Górski
doaj   +1 more source

Home - About - Disclaimer - Privacy